Intraluminal treatment of inoperable oesophageal tumours by intralesional photodynamic therapy with methylene blue (1995)

Peer-Reviewed Study · Orth K; Rück A; Stanescu A; Beger HG · February 25, 1995

Orth K et al., 1995-02-25: Research letter in The Lancet reporting intralesional methylene blue photodynamic therapy for inoperable oesophageal tumours; the companion full report is the Der Chirurg paper (MTM-04) by the same Ulm group.

Intraluminal treatment of inoperable oesophageal tumours by intralesional photodynamic therapy with methylene blue

Orth K et al., 1995-02-25: Research letter in The Lancet reporting intralesional methylene blue photodynamic therapy for inoperable oesophageal tumours; the companion full report is the Der Chirurg paper (MTM-04) by the same Ulm group. Study type: correspondence/research letter. N: not stated in the PubMed record (the Lancet letter predates the Der Chirurg report of 3 patients by the same authors). Country: Germany. Dose/light: not recorded in the PubMed record; presumably the same 1% MB / 665 nm argon-pumped dye laser protocol as MTM-04. Quote is a RECORD FIELD (the article title as indexed in PubMed), not prose from the letter: PubMed carries no abstract for this item. Full text is paywalled at thelancet.com and was not opened, hence MEDIUM confidence. Funder/conflicts: not stated. Use MTM-04 for the substantive clinical detail. Study type: other.